Showing results (1-10 of 132) with videos related to
Sort By:
Pageof 14
Kidney & Blood Pressure Research|April 27, 2025
New Drugs Available for Fabry DiseaseFernando Perretta, Gustavo Cabrera, Juan PoliteiMolecular Genetics and Metabolism Reports|September 14, 2018
Fabry disease. A potential pitfall A family with a novel intronic mutationGustavo Cabrera, Fernando PerrettaMolecular Genetics and Metabolism Reports|May 17, 2017
Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in ArgentinaGustavo Cabrera, Juan Politei, Norberto Antongiovani, et al.Molecular Genetics and Metabolism|June 21, 2020
Fabry disease during the COVID-19 pandemic. Why and how treatment should be continuedJuan PoliteiHealthcare (Basel, Switzerland)|February 25, 2023
Fabry Disease: Switch from Enzyme Replacement Therapy to Oral Chaperone Migalastat: What Do We Know Today?Fernando Perretta, Sebastián JaurretcheGlobal Health, Epidemiology and Genomics|February 27, 2024
Baseline Characteristics of Fabry Disease "Amenable" Migalastat Patients in Argentinian CohortSebastián Jaurretche, Santiago Alonso, Mónica Calvo, et al.Pediatric Nephrology (Berlin, Germany)|July 11, 2018
Clinical parameters, LysoGb3, podocyturia, and kidney biopsy in children with Fabry disease: is a correlation possible?Juan Politei, Valeria Alberton, Oscar Amoreo, et al.Molecular Genetics and Metabolism Reports|June 14, 2017
Prevalence of chronic kidney disease in fabry disease patients: Multicenter cross sectional study in ArgentinaSebastián Jaurretche, Norberto Antogiovanni, Fernando PerrettaNefrologia|March 21, 2019
Fabry nephropathy. Role of nephrologist and clinical variables associated with the diagnosisSebastián Jaurretche, Norberto Antongiovanni, Fernando PerrettaCase Reports in Nephrology|November 4, 2017
Early Renal Involvement in a Girl with Classic Fabry DiseaseFernando Perretta, Norberto Antongiovanni, Sebastián JaurretchePageof 14